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OBJECTIVE: This study compares the clinical, ultrasonography, radiography, and laboratory outcomes of
painless and painful chronic synovitis in patients with established rheumatoid arthritis.
METHODS: This cross-sectional study involved 60 patients with rheumatoid arthritis and synovitis in the
metacarpophalangeal joints; 30 of the patients did not experience pain, and 30 had experienced pain for at
least 6 months prior to the study. The radiocarpal, distal radioulnar, and metacarpophalangeal joints were
evaluated using the ultrasound gray scale, power Doppler, and radiography. Past and present clinical and
laboratory findings were also evaluated.
RESULTS: There were no statistically significant differences between the groups for most of the outcomes. The
group with pain scored worse on the disease activity indices (e.g., DAS 28 and SDAI), function questionnaires
(HAQ and Cochin), and pinch strength test. A logistic regression analysis revealed that the use of an
immunobiological agent was associated with a 3-fold greater chance of belonging to the group that
experienced pain. The painless group had worse erosion scores in the second and fifth metacarpophalangeal
with odd ratios (ORs) of 6.5 and 3.5, respectively. The painless group had more cartilage with grade 4 damage in
the third metacarpophalangeal.
CONCLUSIONS: The rheumatoid arthritis patients with both painless and painful synovitis exhibited similar disease
histories and radiographic and ultrasound findings. However, the ultrasonography evaluation revealed worse scores
in the second and fifth metacarpophalangeal of the synovitis patients who did not experience pain.
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& INTRODUCTION
The clinical presentation of rheumatoid arthritis (RA)
varies, but most patients have intermittent polyarthritis
with swelling and tenderness to palpation (1). Some patients
exhibit persistent chronic synovitis, which is marked by
joint swelling (2) and may or may not be accompanied by
pain. The reason for the absence of pain despite the
persistent joint swelling is unknown. Moreover, little is
known about the predictive factors of painless synovitis
or its relationship to the past progression of the disease,
ultrasound inflammatory findings (e.g., power Doppler), or
the degree of joint damage (erosion).
Ultrasonography (US) allows the early detection of bone
and cartilage damage and the evaluation of synovitis (gray
scale [GS-US] and power Doppler [PD-US]). US is more
sensitive than a clinical examination and simple radio-
graphy (X-ray) (3-8). PD-US enhances the specificity of US
(9), assists in the diagnosis of active synovitis (10), and
predicts joint damage (11).
No previous studies have addressed the importance of
painless chronic synovitis in RA. Thus, the present study
compared the clinical, US, radiographic, and laboratory
outcomes of patients with established RA and chronic
synovitis with or without pain.
& PATIENTS AND METHODS
Study design
This cross-sectional study evaluated RA patients. The
study was approved by the Human Research Ethics
Committee of the Universidade Federal de Sa˜o Paulo/Escola
Paulista de Medicina (Brazil). All patients provided written
informed consent.
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The sample size of 30 individuals in each group was
considered appropriate, and the PD-US was the primary
study outcome. The study had a standard deviation (SD) of
0.4, a power of 90%, and a 5% significance level.
Patients
Adult patients who fulfilled the 1987 American College of
Rheumatology criteria for RA (12) were eligible for the
study if they also met the following criteria: joint swelling
in at least 4 metacarpophalangeal (MCP) joints for at least
6 consecutive months, female gender, and stable use of
disease-modifying antirheumatic drugs (DMARDs) in the
previous 3 months. The visual analogue scale (VAS), which
ranges from 0 to 10 cm, was used for the pain criteria; the
VAS score was at least 4 cm in the painful group and 0 in
the painless group. The following exclusion criteria were
used: overlap syndromes, irreducible deformation and MCP
surgery, and comorbidities, such as uncontrolled hypothyr-
oidism, uncontrolled fibromyalgia or diabetic neuropathy.
Data collection
Sixty patients were selected from the rheumatology
outpatient clinic of the Universidade Federal de Sa˜o Paulo/
Escola Paulista de Medicina (Brazil) between July 2011 and
July 2012. The patients were recruited consecutively and
assigned to the painful synovitis group or the painless
synovitis group. The groups were age matched.
We collected the demographic data, life habits, and
information about both the past and present progression
of RA using a questionnaire.
Clinical examinations were performed by a rheumatolo-
gist who was ‘‘blinded’’ to each patient’s history and the
results of the imaging exams. The evaluation included a
patient and a medical global assessment (on a 0-100 scale),
grip strength using a JamarH, and pinch strength using a
Preston Pinch GaugeH; the 28-joint Disease Activity Score
(DAS 28) (13), Clinical Disease Activity Index (CDAI) (14),
Simplified Disease Activity Index (SDAI) (15), Stanford
Health Assessment Questionnaire (HAQ) (16), and Cochin
Hand Function Scale (CHFS) were also used (17).
The transverse US exam included the dorsal side of the
radiocarpal (RC) and the palmar and dorsal sides of MCPs 1
to 5; the longitudinal US exam included the dorsal radio-
ulnar (DRU), according to a quantitative synovitis mea-
surement (in mm) in the largest synovial bursa and
semiquantitative scores, as described above (Table 1).
Furthermore, a transverse evaluation of the cartilage of
the dorsal side of MCPs 1 to 5 was performed with flexion
of the fingers.
US was performed bilaterally on the hands and wrists by
a ‘‘blinded’’ musculoskeletal sonographer with 5 years of
experience, using the ESAOTE MyLab 60 Xvision, with a
multi-frequency linear transducer (6-18 MHz). The sonogra-
pher followed the guidelines for musculoskeletal US recom-
mended by the European League Against Rheumatism (18).
The US were measured based on the definitions pub-
lished in the Outcome Measures in Rheumatology Clinical
Trials (except cartilage) (19).
Semiquantitative synovitis, bone erosion, and PD-US
were each evaluated using a 4-grade scale ranging from 0
to 3. The scores were defined as follows.
Grades 0-1 for bone erosion and synovitis were consid-
ered normal (Score I), whereas grades 2-3 indicated
pathological changes (Score II) (20).
For the PD-US signal, grade 0 was considered to be nor-
mal (Score I), whereas grades 1-3 were considered to be
pathological (Score II) (20,21).
Joint cartilage was evaluated using a semi-quantitative
5-grade score with the aforementioned categories (22,23).
The inter-observer reliability for the US evaluation was
determined based on the image evaluations recorded on
20% of the overall sample in the RC (a total of 52 joint
recess). The evaluation was performed by a blinded
rheumatologist trained in musculoskeletal US.
The radiological evaluation (plain X-ray of the hands and
wrists) was performed by a single experienced radiolo-
gist who was unaware of the clinical or US findings. The
evaluation used the modified method proposed by van der
Heijde and collaborators (24).
& STATISTICAL ANALYSIS
The data were analyzed in SPSS v.17.0. We express the
quantitative parameters as the mean, standard deviation,
and range. Any value of p,0.05 was consider significant.
The data were compared using either the Student’s t-test
or the Mann-Whitney test.
The categorical variables were measured in percentages
and were compared between the groups, using either the
chi-squared or Fisher’s exact tests. The correlations be-
tween variables were evaluated using either Pearson’s or
Spearman’s correlation coefficients. Cohen’s Kappa index
and the intraclass correlation coefficient were used to
evaluate the inter-observer reliability.
A subanalysis of the 2 groups was performed on the US
findings for the joints that exhibited swelling in the clinical
examination. Logistic regression analysis was applied to the
semi-quantitative US variables to assess the ability of the
Table 1 - Semiquantitative scores for synovitis, PD-US, bone-erosion and cartilage.
Synovitis (19): PD-US (19):
0 no synovial thickening 0 no flow in the synovium
1 minimal synovial thickening 1 single vessel signals
2 moderate synovial thickening with capsule distension 2 confluent vessel signals in less than half of the area evaluated
3 synovial thickening, extending to bone diaphysis 3 vessel signals in more than half of the evaluated area
Bone erosion (19): Cartilage (22):
0 regular bone surface 0 normal hyaline cartilage
1 bone surface irregularity 1 loss of the sharpness of the cartilage margin
2 bone surface defect on 2 planes 2 partial thickness defect of the cartilage layer
3 bone defect with bone destruction 3 full thickness of the cartilage layer
4 grade 3 + subchondral bone involvement
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variables to predict painful or painless synovitis and to
identify the variables that were likely to be predictive of
painless synovitis.
& RESULTS
The sample consisted of 60 patients with established RA,
for a total of 120 hands and wrists and 600 MCFs. The mean
duration of the absence of joint pain in the painless group
and the presence of joint pain in the painful group
was, respectively, 30.3¡32.6 months and 50.9¡74.6 months
(p= 0.740). There were no statistically significant differences
between the groups for the majority of the demographic
variables and laboratory findings or in the disease progres-
sion (Tables 2, 3).
Two patients in the painless group (7%) and 9 patients
(30%) in the painful group were smokers (p= 0.042) (Table 2).
The medical diagnosis for RA took 13.2¡23.6 months in
the painless group and 21.2¡26.1 months in the painful
group (p= 0.028) (Table 3). The majority of patients were
initially treated with monotherapy consisting of a DMARD
associated with a corticosteroid. Furthermore, the majority
of patients were primarily treated with a combination of
DMARDs (Table 3).
There were statistically significant between-groups differ-
ences in the current DAS-28 measurement (using erytrocyte
sedimentation rate-ESR) and for all variables influenced by
the presence of joint pain, with higher scores in the painful
group (p,0.05) (Tables 2 and 4). However, there was no
statistically significant difference between the groups in the
number of swollen joints.
Twenty-seven patients (90%) in the painless group and 13
(43%) patients in the painful group were classified as having
mild dysfunction (HAQ scores 0 and 1, respectively) (25)
(p= 0.001). There were statistically significant between-
group differences for the CHFS, lateral pinch, and tripod
pinch (p,0.001, p,0.001, and p= 0.039, respectively), with
better scores in the painless group. The Jamar and pulp-to-
pulp pinch scores were similar between the groups. There
were no statistically significant between-group differences
in the degree of joint deformities or in the number of prior
surgeries (Table 3).
The most frequently used DMARDs in both groups at the
time of the study were methotrexate and leflunomide. More
than half of the painful group used corticosteroids but at a
low mean dose of 5.0 mg¡6.76 mg (Table 2). Eleven
patients in the painful group and 5 patients in the painless
group used immunobiological agents (p= 0.080).
In the univariate logistic regression analysis, only the
variable ‘‘used an immunobiological agent after one year of
the disease’’ was associated with painful synovitis; how-
ever, it was associated with a 3-fold increase in the odds
of the patient belonging to the painful group (odds ratio
[OR] = 3.0, 1.00-9.37, p= 0.049).
A total of 1.560 joint recesses were examined in the US
evaluation. In the semi-quantitative analysis, there were no
Table 2 - Group characteristics.
PAINLESS GROUP
mean ¡ SD (%) (N = 30)
PAINFUL GROUP
mean ¡ SD (%) (N = 30) p-value
Age (in years) 59.9¡11.5 56.8¡14.0 0.441*
Skin color White(%)/Brown(%)/Black(%) 16(55)/10(35)/3(10) 11(41)/11(41)/5(18) 0.496**
Smoking 2 (7) 9 (30) 0.042***
Alcohol use 0 (0) 1 (3) 0.500***
Dominant right hand 28 (93) 27 (90) 1.000***
Arterial hypertension 15 (50) 23 (77) 0.032**
Dyslipidemia 8 (27) 15 (50) 0.063**
Other comorbidities OP/Fibromyalgia/Others 8(27)/1(3)/1(3) 5(17)/0(0)/4(13) 0.319**
Disease duration (years) 17.7¡9.4 15.1¡10.2 0.185‘
Duration of the absence or presence of MCP pain (months) 30.3¡32.6 50.9¡74.6 0.740‘
Rheumatoid factor positive 13 (43) 13 (43) 1.000 **
Anti-CCP positive 23 (77) 19 (63) 0.269 **
Use of MTX 17 (57) 20 (67) 0.426**
Use of Leflunomide 18 (60) 13 (43) 0.196**
Use of Hydroxychloroquine 1 (3) 4 (13) 0.353***
Use of CS via oral 11 (37) 16 (53) 0.194**
Dose of CS via oral (in mg) 2.08¡3.09 5.00¡6.76 0.097‘
Use of immunobiological agent 5 (17) 11 (37) 0.080**
DMARD association 9 (30) 11 (37) 0.584**
Morning stiffness (minute) 4.7¡13.3 24.8¡29.0 ,0.001‘
ESR 31.7¡21.8 31.5¡25.9 0.723‘
CRP (mg/dl) 0.75¡1.00 0.68¡0.69 0.706‘
MDGA 33.3¡15.6 48.3¡14.9 ,0.001‘
PGA 30.7¡26.8 60.0¡19.3 ,0.001‘
N painful joints 1.5¡2.3 13.6¡6.1 ,0.001‘
N swollen joints 8.4¡3.0 9.6¡3.9 0.246‘
DAS 28 by ESR 3.75¡0.83 5.57¡0.94 ,0.001*
DAS 28 by CRP (mg/L) 3.06¡0.86 4.90¡0.95 ,0.001*
SDAI 16.17¡6.74 30.21¡9.52 ,0.001*
CDAI 15.3¡6.5 28.9¡9.1 ,0.001*
SD: standard deviation; * Student’s t-test; ** chi-squared test; ‘ Mann-Whitney U-test; *** Fisher’s exact test; OP: osteoporosis;
MCPs: metacarpophalangeal joints; T: time; Anti-CCP: anti-cyclic citrullinated peptide; MDGA: physician’s global assessment; PGA: patient’s global
assessment; N: number; DAS-28: 28-Joint Disease Activity Score; SDAI: Simplified Disease Activity Index; CDAI: Clinical Disease Activity Index; CRP:
C-reactive protein; ESR: erythrocyte sedimentation rate (mm/h); mg: milligrams; CS: corticosteroid (mg); MTX: methotrexate; DMARDs: disease-modifying
antirheumatic drugs; DMARD association: $2.
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statistically significant between-group differences for the
presence of synovitis (at least grade 2) or positive PD-US
(Figure 1) in the majority of the joint recesses studied. Bone
erosion (at least grade 2) was similar in the 2 groups, but
the painless group had worse scores in some joints (Table 5).
Statistically significant differences were found in the
cartilage evaluation, with more scores of 4 in the third
MCP in the painless group (p,0.004) and more scores of 2
in the second MCP (p,0.022) and 1 in the fourth MCP
(p,0.004) in the painful group.
Fifty-eight percent of the wrists in the painful group had
pain on clinical examination, and 83% of the wrists in the
painless group had no pain.
In the US subanalysis of the joints with swelling, there
were no statistically significant between-group differences
in the quantitative synovitis, the semi-quantitative synovitis,
or the PD-US in the MCPs. The bone erosion scores were
worse in the painless group for the palmar and lateral sides
of the second MCP (p,0.022 and p,0.004, respectively).
Regarding the joint cartilage, only the third MCP had more
0 scores in the painful group (p,0.030).
The univariate logistic regression revealed a greater
likelihood of patients belonging to the painless group based
on worse US scores for the following variables (Figure 2):
the semiquantitative synovitis in the DRU, the PD-US in the
RC, the erosion on the dorsal face of the 2nd MCP and the
dorsal face of the 5th MCP, and the DRU (OR = 2.5, 1.09-5.64,
p= 0.029; OR = 2.3, 1.07-5.16, p= 0.034; OR = 6.5, 1.76-23.77,
p= 0.005; OR = 3.5, 1.06-11.57, p = 0.040; and OR = 5.7, 1.54-
20.98, p= 0.009, respectively). The interobserver reliability
was moderate to strong (Kappa = 0.435 to 1.00; p,0.018) for
all US measures and strong for the PD-US (Kappa = 0.655 to
0.783, p= 0.001).
No statistically significant differences were found in the
radiographic evaluation, except for the proximal interpha-
langeal (PIP) joint, for which the painless group had a worse
Table 3 - Past disease variables of the groups.
PAINLESS GROUP
mean ¡ SD (%) (N=30)
PAINFUL GROUP
mean ¡ SD (%) (N=30) p-value
Use of MTX initially 12 (41) 13 (43) 0.879*
Dose of MTX initially 4.91¡7.29 5.89¡8.17 0.675**
Monotherapy initially 20 (67) 18 (60) 0.592*
DMARD association initially 6 (20) 6 (20) 1.000*
Use of CS initially 21 (70) 21 (70) 0.611*
Dose of CS initially 7.04¡7.24 9.28¡9.20 0.413**
Time of use of CS initially (months) 70.1¡98.1 33.7¡57.5 0.504**
Monotherapy during . part of the disease 11 (37) 6 (21) 0.176*
DMARD association during . part of the disease 18 (60) 22 (76) 0.192*
Use of NSAID during . part of the disease 5 (17) 1 (3) 0.105***
Use of biological agent after 1 year of the disease 7 (23) 14 (48) 0.045*
Change of biological agent 6 (20) 7 (24) 0.701 *
Use of MTX any T of disease 29 (97) 27 (96) 1.000***
Use of HDQ any T of disease 24 (80) 19 (68) 0.291*
Use of Leflunomide any T of disease 24 (80) 22 (79) 0.893*
Use of SSZ any T of disease 7 (23) 9 (32) 0.453 *
Joint impairment initially Polyarticular/Monoarticular 26 (87)/04(13) 22 (73)/08(27) 0.333***
Joints initially affected: Hands/Hands and feet/Lower limbs 13(45)/11(38)/5(17) 15(53)/6(21)/4(14) 0.548*
T until seeking physician (months) 7.9¡22.2 9.7¡23.0 0.526**
T until diagnosis (months) 13.2¡23.6 21.2¡26.1 0.028**
N˚ of past IAI 3.9¡3.2 4.3¡3.8 0.942**
N˚ of IAI in hand joints 1.6¡2.5 2.5¡3.7 0.940**
Deformity in hands 19 (63) 20 (69) 0.599 *
Deformity in feet 7 (23) 7 (25) 0.562 *
Joint surgeries 4 (13) 4 (13) 0.362 *
SD: standard deviation; MTX: methotrexate; * chi-squared test; ** Mann-Whitney U-test; *** Fisher’s exact test; CS: corticosteroid; T: time;
NSAID: non-steroidal anti-inflammatory drug; SSZ: sulfasalazine; N: number; IAI: intra-articular injection; HDQ: hydroxychloroquine.
Table 4 - Current functional assessment of the groups.
PAINLESS GROUP
mean ¡ SD % (N = 30)
PAINFUL GROUP
mean ¡ SD % (N = 30) p-value
HAQ 0.43¡0.41 1.10¡0.56 ,0.001‘
HAQ categorized Mild/mod/severe dysfunction 27 (90)/3 (10)/0 (0) 13 (43)/16 (53)/1(3) 0.001**
Functional Class 1/2/3 17(57)/10(35) 2 (7) 11(37)/19(63)/0 (0) 0.048**
Cochin 8.2¡9.9 24.8¡15.9 ,0.001‘
Jamar 20.35¡12.80 18.42¡13.89 0.284‘
Lateral pinch 4.69¡1.45 3.71¡1.59 ,0.001‘
Pulp-to-pulp pinch 2.92¡1.27 2.56¡1.21 0.069‘
Tripod pinch 3.45¡1.44 2.99¡1.55 0.039‘
SD: standard deviation; mod: moderate; ‘Mann-Whitney U-test; ** chi-squared test; HAQ: Stanford Health Assessment Questionnaire; CHFS: Cochin Hand
Function Scale.
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joint space reduction score (p= 0.018). The mean total Sharp
score was 93.2¡61.6 in the painless group and 65.4¡40.6 in
the painful group (p= 0.114).
& DISCUSSION
Pain control is a priority in 90% of patients with RA.
However, in a prospective study, Lee et al. (26) demon-
strated that the number of joints with swelling at baseline
was negatively associated with the presence of pain in a
1-year follow-up period. The perception of pain is highly
subjective and may be influenced by a number of issues,
including socio-cultural factors (27-29).
Few studies have assessed painless synovitis in RA. The
absence of pain in patients with juvenile idiopathic arthritis can
delay the disease diagnosis, which could lead to great-
er joint damage and disability (30,31). The significance of
painless synovitis for physicians and patients remains unknown.
In the present study, the majority of both the past
and present variables were similar in the patients with
and without pain. The time until the RA diagnosis was
longer for patients in the painful group. Pain or the
absence of pain may not be constant for each patient
throughout the disease course. Smoking is an aggravat-
ing factor for RA (32); this issue was also observed in this
study through the association between smoking and
painful synovitis.
The painful group had worse disease activity indices
(DAS 28, SDAI, and CDAI), a greater number of painful
joints, and worse overall evaluations by both the physician
and patient. However, the DAS 28 may not be a good
measure of disease activity (33) because joint pain is
weighted twice as swelling in the DAS 28 score.
Felson et al. (33) have argued that joint swelling is the
true predictor of late radiographic progression in RA. In a
prospective cohort study, Lukas et al. (34) have found that
Figure 1 - Dorsal longitudinal image of 2nd MCP; (A) Patient in group without pain with synovial hypertrophy and positive PD signal; (B)
Patient in Painful group with synovial hypertrophy and positive PD signal; M=metacarpal; P =phalange.
Table 5 - Ultrasound findings for each joint.
QUANTITATIVE SYNOVITIS
in mm Mean (SD)
ABNORMAL SYNOVITIS
SCORES (2-3) N (%)
ABNORMAL POWER
DOPPLER SCORES (1-3) N (%)
ABNORMAL BONE EROSION
SCORES (2-3) N (%)
JR
PAINLESS
N = 60
PAINFUL
N = 60 p-value
PAINLESS
N = 60
PAINFUL
N = 60 p-value
PAINLESS
N = 60
PAINFUL
N = 60 p-value
PAINLESS
N = 60
PAINFUL
N = 60 p-value
RC 3.0 (2.0) 2.8 (2.2) 0.308 22 (36.7) 18 (30.0) 0.439 25 (41.7) 14 (23.3) 0.032 57 (95.0) 53 (88.3) 0.186
DRU 3.3 (2.3) 3.0 (2.1) 0.542 23 (38.3) 12 (20.0) 0.027 25 (41.7) 16 (26.7) 0.083 56 (94.9) 46 (76.7) 0.004
1st
MCP
P
D
1.7 (1.6)
1.7 (1.7)
1.4 (1.8)
1.4 (1.5)
0.312
0.298
36 (60.0)
35 (58.3)
29 (48.3)
30 (50.0)
0.200
0.360
15 (25.0)
13 (21.7)
8 (13.3)
12 (20.0)
0.104
0.822
51 (85.0)
47 (78.3)
42 (70.0)
40 (66.7)
0.049
0.152
2nd
MCP
P
D
L
2.2 (2.0)
2.6 (2.1)
1.9 (1.9)
2.4 (1.9)
0.304
0.404
27 (45.0)
34 (56.7)
19 (31.7)
24 (40.0)
0.133
0.068
13 (21.7)
27 (45.0)
11 (18.3)
17 (28.3)
0.648
0.058
53 (88.3)
54 (90.0)
57 (95.0)
44 (73.3)
51 (85.0)
44 (74.6)
0.037
0.408
0.002
3rd
MCP
P
D
1.5 (1.8)
1.9 (1.8)
1.4 (1.7)
1.9 (1.8)
0.694
0.850
20 (33.3)
21 (35.0)
15 (25.0)
18 (30.0)
0.315
0.559
09 (15.0)
16 (26.7)
08 (13.3)
14 (23.3)
0.793
0.673
42 (70.0)
51 (85.0)
42 (70.0)
43 (71.7)
1.000
0.076
4th
MCP
P
D
1.3 (1.7)
1.4 (1.7)
0.9 (1.3)
1.4 (1.9)
0.274
0.993
14 (23.3)
23 (38.3)
09 (15.0)
19 (31.7)
0.246
0444
03 (5.0)
09 (15.0)
03 (5.0)
10 (16.7)
1.000
0.803
34 (57.6)
33 (55.0)
29 (49.2)
28 (46.7)
0.356
0.361
5th
MCP
P
D
1.4 (2.2)
2.1 (2.0)
1.2 (1.6)
1.9 (2.1)
0.906
0.616
14 (3.7)
23 (38.3)
13 (21.7)
19 (31.7)
0.827
0.444
06 (10.0)
11 (18.3)
6 (10.2)
11 (18.3)
0.976
1.000
33 (55.0)
56 (93.3)
22 (37.3)
48 (80.0)
0.053
0.032
JR: joint recesses; RC: radiocarpal; DRU: distal radioulnar; P: palmar; D: dorsal; L: lateral; MCP: metacarpophalangeal; Statistical tests – Pearson’s
chi-squared test; Mann-Whitney U-test.
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joint swelling was the greatest predictor of ‘‘repair’’ in
radiographic erosion. Studying early arthritis, Filler et al.
(35) have also found that the progression of RA was more
closely associated with the swollen joint count than with the
tenderness joint count (35).
Recently, Dougados et al. (36) have emphasized the
importance of persistent synovitis (both clinical and US
examination) for predicting subsequent structural deteriora-
tion in RA patients. In his study, the level of clinical disease
activity was defined by the number of swollen joints.
Furthermore, the patients who had synovitis at baseline had
more structural progression (OR = 2.01, 1.36-2.98, p,0.001)
in a 2-year follow-up period (36).
In this study, worse functional and dynamometric scores
were found in the painful group. It is unsurprising that
individuals with painful joints at the time of evaluation had
worse functional scores than those without joint pain
(37). Nonetheless, no statistically significant between-group
differences were found with respect to the grip strength or
the pulp to pulp pinch strength.
Figure 2 - Probability of belonging to painless synovitis group with presence of Score II semi-quantitative synovial hypertrophy, PD and
erosion in relation to Score 1 in joint recesses with statistically significant difference in the previous ultrasonographic evaluation and
significant difference in regression analysis (p , 0.05); Statistical test: univariate logistic regression; OR = odds ratio; n = number.
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Subclinical synovitis may be present in RA remission (8).
Furthermore, there is evidence indicating the progression of
joint damage in RA patients during clinical remission
(11,10), which may be related to residual joint swelling (2).
The consideration of persistent joint swelling in RA patients,
even in the absence of pain, as in the present study, aligns
with the hypothesis that residual swelling causes erosion
and is contrary to the notion of ‘‘cold,’’ ‘‘fibrous,’’ and
innocuous synovitis.
US has been proven effective at detecting subclinical
synovitis (38,8,5), and PD-US is an important tool for
detecting active synovitis (10,39). In this study, no differ-
ences were found between the painful and painless groups
for the majority of US variables in the MCPs and wrists.
The detection of the PD-US signal is a predictor of disease
evolution in RA (35) and also of the progression of joint
damage (11) and the reactivation of the disease (40). In this
sample, PD-US was detected in 21% of the joint recesses
analyzed, with no significant between-group differences for
the majority of joint recesses. This result suggests that there
is no association between active synovitis and the presence
of joint pain. US also allows for earlier detection of erosion
than plain x-rays. In this respect, US is comparable to
magnetic resonance imaging (41-43). In the US analysis of
erosion, 5 joint recesses were statistically different between
groups, with worse scores in the painless group. For the
joint cartilage, poorer scores were found more frequently in
the painless group, although the between-group difference
did not achieve statistical significance.
The similarities between the painful and painless groups
in the quantitative analysis of synovial hypertrophy, semi-
quantitative analysis of GS-US variables, PD-US, and bone
erosion may mean that painless synovitis can still result in
joint damage and disability. Moreover, painless synovitis
may make the patient and physician more passive in
optimizing treatment. This hypothesis is in agreement with
the findings that, after the first year of the disease, the
painful group were more likely to use immunobiological
agents (p= 0.045), and patients with worse US scores in
some joint recesses were more likely to be in the painless
group.
The radiographic analysis demonstrated that major
previous structural damage was similar in both groups,
except for IFP scores, which were worse in the painless
group. This evidence further indicates that the continual
presence of synovitis, instead of joint pain, is an important
factor influencing structural damage in RA because both
groups had a similar history of radiographic progression.
These findings also aligned with the present analysis
regarding the identification of joint deformities; there were
no statistically significant differences between groups.
However, a controlled prospective study with US and
radiographic evaluations is needed to compare the evolu-
tion of structural joint damage in this sample of patients.
One of the limitations of this study is that was impossible
to recruit patients in the painless group who had a complete
absence of pain in all joints. The difficulty in obtain-
ing individuals with a constant pain status (presence or
absence) throughout the progression of RA constitutes
another study limitation. This study is the first to compare
patients with RA and painless synovitis with those patients
with painful synovitis using clinical, ultrasonographic and
radiographic variables. The majority of the findings suggest
that patients with painless synovitis exhibit a similar profile
to those patients with painful synovitis with respect to the
presence of active synovitis and past joint damage.
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